Electronic Signatures for Clinical Trial Documents
A White Paper
HAGERSTOWN, MD., August 8, 2020 — ACRO continues to lead the way on ensuring our clients are aware and continue to meet regulatory bodies requirements. Due to the COVID-19 pandemic, the use of electronic signatures has become more vital as remote work and the risk associated with handling physical documents with wet signatures has increased. ACRO has been at the forefront of these changes, and recently provided one of our clients with a white paper giving guidance on the practical application of 21 CFR Part 11 as it relates to the creation of authentic and compliant electronic signatures, using Adobe software.
Please visit our site often to get the most current publications.
Ensuring 21 CFR Part 11 Compliance